Advertisement #1
Axplora
Home Tags FDA

Tag: FDA

Project Optimus: How to Prepare for Success

Julie Bullock, Pharm.D. -
Low magnification micrograph of mantle cell lymphoma of the terminal ileum. Endoscopic biopsy. H&E stain. Photo Courtesy: 2020. Nephron. This file is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported license.

U.S. FDA approves Phase 3 Study Design for Zilovertamab in the...

Editorial Team -

More Education is Needed to Increase Provider Geriatric Assessments for Older...

Editorial Team -

Disitamab Vedotin Receives FDA Breakthrough Therapy Designation for Treatment of Urothelial...

Peter Hofland, Ph.D -
Merck | MSD Exhibition booth at the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Peter Hofland, Ph.D -
Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith -
Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

FDA Approves New Drug for Advanced Bladder Cancer

Peter Hofland, Ph.D -
Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

Biologics License Application and Priority Review for Enfortumab Vedotin in Urothelial...

Peter Hofland, Ph.D -

FDA Approves Pfizer’s Biosimilar rituximab-pvvr for Certain Cancers and Autoimmune Conditions

Peter Hofland, Ph.D -

United States and Europe Reach Milestone Agreement on Mutual Recognition of...

Danielle Garcia -
12Page 1 of 2

LATEST NEWS

Advertisment #12
© 2001 - 2020 Sunvalley Communication, LLC. All Rights Reserved.

X